FY26 Half Year Financial Results
Filed with ASX · · 5 pages · English
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call• BCRL – Reimbursement now 323M U.S. covered lives, 93% national coverage up from 87% at Q1 FY26 - supportive of near-term growth prospects. Since 1 July 2025, the number of states with coverage above 90% increased from 7 to 39. States over 95% coverage continues to improve, doubling from the last quarter, up from 14 to 27. • Heart Health - First sales achieved at an integrated delivery network (I
Story so far
Earlier from Impedimed
- ImpediMed Appoints Medical Technology Commercialization Expert Erik Anderson to Board of Directors
- Quarterly Activities Report and Appendix 4C - Dec-2025
- Quarterly Activities Report and Appendix 4C - Sep-2025 Qtr
- Major US health insurer publishes positive coverage
- Appendix 4E
Later from Impedimed
- Appointment of CEO/Managing Director
- ImpediMed Appoints Erik Anderson as Chief Executive Officer
- Quarterly Activities Report and Appendix 4C - Mar-2026 Qtr
- ImpediMed announces a successful $15.2 million Capital Raise
- Equity Raising Investor Presentation
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed